"A trusted leader in providing faith-based, integrated healthcare, Franciscan Health Hammond is one of the largest acute-care hospitals in the Northwest Indiana region."

During the past decade, Franciscan Saint Margaret Health-Hammond Campus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Franciscan Saint Margaret Health-Hammond Campus" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Franciscan Saint Margaret Health-Hammond Campus" are "Cervical Cancer" (2 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials), "Endometrial Serous Adenocarcinoma" (2 trials), "Stage II Uterine Corpus Cancer AJCC v7" (2 trials) and "Adult Giant Cell Glioblastoma" (1 trials). Many other conditions were trialed in "Franciscan Saint Margaret Health-Hammond Campus" in a lesser frequency.

Most popular intervention types in "Franciscan Saint Margaret Health-Hammond Campus" are "Drug" (5 trials), "Radiation" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "3-Dimensional Conformal Radiation Therapy" (3 trials), "Carboplatin" (2 trials), "Internal Radiation Therapy" (2 trials), "Paclitaxel" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Franciscan Saint Margaret Health-Hammond Campus" are 4 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Franciscan Saint Margaret Health-Hammond Campus". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Franciscan Saint Margaret Health-Hammond Campus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Franciscan Saint Margaret Health-Hammond Campus, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".